Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
70.90
-1.62 (-2.23%)
Aug 13, 2025, 4:00 PM - Market closed
Arcellx Employees
Arcellx had 163 employees as of December 31, 2024. The number of employees increased by 33 or 25.38% compared to the previous year.
Employees
163
Change (1Y)
33
Growth (1Y)
25.38%
Revenue / Employee
$349,564
Profits / Employee
-$1,153,307
Market Cap
3.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 163 | 33 | 25.38% |
| Dec 31, 2023 | 130 | 32 | 32.65% |
| Dec 31, 2022 | 98 | 20 | 25.64% |
| Dec 31, 2021 | 78 | 47 | 151.61% |
| Dec 31, 2019 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ACLX News
- 6 days ago - Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025 - Seeking Alpha
- 6 days ago - Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights - Business Wire
- 4 weeks ago - Arcellx: Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market - Seeking Alpha
- 3 months ago - Arcellx Announces Its Participation at TD Cowen's 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Business Wire
- 3 months ago - Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma - Business Wire
- 3 months ago - Arcellx Provides First Quarter 2025 Financial Results and Business Highlights - Business Wire
- 3 months ago - Baron Health Care Fund Q1 2025 Top Net Purchases And Sales - Seeking Alpha
- 3 months ago - Baron Health Care Fund Q1 2025 Top Contributors And Detractors - Seeking Alpha